Diffuse Splenic Uptake on 99mTc MDP Bone Scintigraphy Secondary to Transfusion-Related Hemosiderosis
A 70-year-old woman with a past medical history of breast cancer is undergoing surveillance. She also had a history of repeated blood transfusions for refractory anemia caused by treated marrow metastatic disease. Laboratory tests showed elevated AST (50 U/L) and ALT (115 U/L). 99mTc MDP bone scintigraphy revealed intense diffuse splenic uptake. No splenic calcifications or infarcts were found on contrast-enhanced CT. MRI demonstrated signal dropout on in-phase sequences and marked T2 hypointensity of the spleen and liver, without focal splenic lesions, suggesting transfusion-related secondary hemosiderosis. Iron overload should be considered when diffuse splenic uptake is observed on bone scintigraphy.
Authors
- A Sha'aban
- Kathryn Morton
- Khaled M. Elsayes (ORCID: https://orcid.org/0000-0003-0184-0717)
- Ola A. E. Mohamed (ORCID: https://orcid.org/0009-0002-3502-6529)
- Ahmed Ebada Salem
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of Utah (US)
- Orthopedic Specialty Hospital (US)
- Mayo Clinic in Arizona (US)
- Alexandria University (EG)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2026-06-17
- DOI
- https://doi.org/10.1097/rlu.0000000000006580
- Primary Topic
- Medical Imaging and Pathology Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00